Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
inflammatory5866 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A08770 | 31991386 | Biomed Pharmacother | MiR-195 regulates CD40 to maintain Th17/Treg balance in rats with non-alcoholic fatty liver disease. | 2020 | Details |
| A08777 | 31987259 | Complement Ther Med | The effects of curcumin supplementation on liver function, metabolic profile and body composition in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials. | 2019 | Details |
| A08782 | 31986416 | Biomed Pharmacother | Salidroside improves high-fat diet-induced non-alcoholic steatohepatitis by regulating the gut microbiota-bile acid-farnesoid X receptor axis. | 2020 | Details |
| A08783 | 31986085 | Annu Rev Med | Hiding in Plain Sight: Interleukin-11 Emerges as a Master Regulator of Fibrosis, Tissue Integrity, and Stromal Inflammation. | 2020 | Details |
| A08793 | 31982140 | Biochem Biophys Res Commun | Targeting DUSP16/TAK1 signaling alleviates hepatic dyslipidemia and inflammation in high fat diet (HFD)-challenged mice through suppressing JNK MAPK. | 2020 | Details |
| A08801 | 31980690 | Sci Rep | Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitis. | 2020 | Details |
| A08821 | 31978521 | J Ethnopharmacol | Phenols fragment of Veronica ciliata Fisch. ameliorate free radical-induced nonalcoholic fatty liver disease by mediating PI3K/Akt signaling pathway. | 2020 | Details |
| A08826 | 31975365 | Histol Histopathol | Cathepsin-B dependent autophagy ameliorates steatoheaptitis in chronic exercise rats. | 2020 | Details |
| A08831 | 31973813 | Biochem Biophys Res Commun | PTUPB ameliorates high-fat diet-induced non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in mice. | 2020 | Details |
| A08833 | 31972071 | Cell Physiol Biochem | Integrin Linked Kinase (ILK) Downregulation as an Early Event During the Development of Metabolic Alterations in a Short-Term High Fat Diet Mice Model. | 2020 | Details |
| A08839 | 31969775 | World J Gastroenterol | Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C. | 2020 | Details |
| A08840 | 31969650 | Sci Rep | Dipeptidyl peptidase-4 inhibition prevents nonalcoholic steatohepatitis-associated liver fibrosis and tumor development in mice independently of its anti-diabetic effects. | 2020 | Details |
| A08841 | 31969314 | Pak J Pharm Sci | REVIEW- Contemporary evidence on the dynamic role of probiotics in liver diseases. | 2019 | Details |
| A08852 | 31965894 | Gut Microbes | Lactobacillus and Pediococcus ameliorate progression of non-alcoholic fatty liver disease through modulation of the gut microbiome. | 2020 | Details |
| A08860 | 31959914 | Cell Death Differ | Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD/NASH. | 2020 | Details |
| A08865 | 31957809 | Biochem J | C-Jun/C7ORF41/NF-κB axis mediates hepatic inflammation and lipid accumulation in NAFLD. | 2020 | Details |
| A08866 | 31957704 | Eur Cytokine Netw | lncRNA NEAT1 regulates fibrosis and inflammatory response induced by nonalcoholic fatty liver by regulating miR-506/GLI3. | 2019 | Details |
| A08873 | 31955065 | Int Immunopharmacol | Baicalin and its nanoliposomes ameliorates nonalcoholic fatty liver disease via suppression of TLR4 signaling cascade in mice. | 2020 | Details |
| A08879 | 31953865 | Hepatology | Indole Alleviates Diet-Induced Hepatic Steatosis and Inflammation in a Manner Involving Myeloid Cell 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 3. | 2020 | Details |
| A08883 | 31953228 | Biochim Biophys Acta Mol Cell Biol Lipids | Effects of peptidoglycan on the development of steatohepatitis. | 2020 | Details |
| A08888 | 31952262 | Int J Mol Sci | Beneficial Effects of SREBP Decoy Oligodeoxynucleotide in an Animal Model of Hyperlipidemia. | 2020 | Details |
| A08891 | 31950772 | Diabetes Metab J | Combination of Probiotics and Salvia miltiorrhiza Polysaccharide Alleviates Hepatic Steatosis via Gut Microbiota Modulation and Insulin Resistance Improvement in High Fat-Induced NAFLD Mice. | 2019 | Details |
| A08894 | 31949886 | Oxid Med Cell Longev | Peroxiredoxin 6 Is a Key Antioxidant Enzyme in Modulating the Link between Glycemic and Lipogenic Metabolism. | 2019 | Details |
| A08901 | 31947953 | J Clin Med | Randomised Clinical Trial: Calorie Restriction Regimen with Tomato Juice Supplementation Ameliorates Oxidative Stress and Preserves a Proper Immune Surveillance Modulating Mitochondrial Bioenergetics of T-Lymphocytes in Obese Children Affected by Non-Alcoholic Fatty Liver Disease (NAFLD). | 2020 | Details |
| A08913 | 31941015 | Int J Mol Sci | Sarcopenic Obesity, Insulin Resistance, and Their Implications in Cardiovascular and Metabolic Consequences. | 2020 | Details |
| A08925 | 31935815 | Int J Mol Sci | Antrodan Alleviates High-Fat and High-Fructose Diet-Induced Fatty Liver Disease in C57BL/6 Mice Model via AMPK/Sirt1/SREBP-1c/PPARγ Pathway. | 2020 | Details |
| A08933 | 31931543 | Z Gastroenterol | [What is the (right) target for non-alcoholic fatty liver disease (NAFLD)?] | 2020 | Details |
| A08934 | 31931541 | Z Gastroenterol | A young patient with type 2 diabetes associated non-alcoholic steatohepatitis, liver cirrhosis, and hepatocellular carcinoma. | 2020 | Details |
| A08937 | 31930901 | Zhongguo Zhen Jiu | [Mechanism of catgut embedding at back-shu points for nonalcoholic steatohepatitis based on IKK/IKB/NF-κB signaling pathway]. | 2020 | Details |
| A08946 | 31929156 | J Alzheimers Dis | Staging Alzheimer's Disease in the Brain and Retina of B6.APP/PS1 Mice by Transcriptional Profiling. | 2020 | Details |
| A08951 | 31928222 | Am J Physiol Gastrointest Liver Physiol | Nanoformulated SOD1 ameliorates the combined NASH and alcohol-associated liver disease partly via regulating CYP2E1 expression in adipose tissue and liver. | 2020 | Details |
| A08954 | 31926984 | J Ethnopharmacol | Sweroside ameliorates NAFLD in high-fat diet induced obese mice through the regulation of lipid metabolism and inflammatory response. | 2020 | Details |
| A08972 | 31920355 | Diabetes Metab Syndr Obes | Salidroside-Mitigated Inflammatory Injury of Hepatocytes with Non-Alcoholic Fatty Liver Disease via Inhibition TRPM2 Ion Channel Activation. | 2019 | Details |
| A08975 | 31919231 | Gut | S100A11/ANXA2 belongs to a tumour suppressor/oncogene network deregulated early with steatosis and involved in inflammation and hepatocellular carcinoma development. | 2020 | Details |
| A08999 | 31909357 | Hepatol Commun | A Microphysiological System for Studying Nonalcoholic Steatohepatitis. | 2019 | Details |
| A09006 | 31907123 | Zhongguo Yi Xue Ke Xue Yuan Xue Bao | [Intervention of Catalpol on High-fat Diet Induced Nonalcoholic Fatty Liver Disease in Mice]. | 2019 | Details |
| A09011 | 31905026 | Am J Physiol Gastrointest Liver Physiol | Addition of trans fat and alcohol has divergent effects on atherogenic diet-induced liver injury in rodent models of steatohepatitis. | 2020 | Details |
| A09012 | 31905025 | Am J Physiol Gastrointest Liver Physiol | Investigating fibrosis and inflammation in an ex vivo NASH murine model. | 2020 | Details |
| A09019 | 31902937 | Biol Pharm Bull | Repeated Administration of Kupffer Cells-Targeting Nanoantioxidant Ameliorates Liver Fibrosis in an Experimental Mouse Model. | 2020 | Details |
| A09041 | 31892608 | Anticancer Res | Vitamin D in Preclinical Models of Fatty Liver Disease. | 2020 | Details |
| A09045 | 31890671 | J Diabetes Metab Disord | The effect of Nigella sativa oil on serum levels of inflammatory markers, liver enzymes, lipid profile, insulin and fasting blood sugar in patients with non-alcoholic fatty liver. | 2019 | Details |
| A09058 | 33837698 | Curr Top Membr | Membrane modulatory effects of omega-3 fatty acids: Analysis of molecular level interactions. | 2020 | Details |
| A09065 | 31887369 | J Hepatol | A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis. | 2019 | Details |
| A09070 | 31885103 | Fundam Clin Pharmacol | Comparative effectiveness of phosphodiesterase 3, 4, and 5 inhibitors in amelioration of high-fat diet-induced nonalcoholic fatty liver in rats. | 2020 | Details |
| A09071 | 31885010 | Iran J Immunol | Circulating Levels of Pro-inflammatory Cytokines in Patients with Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. | 2019 | Details |
| A09078 | 31882889 | Sci Rep | Hepatic Mitochondrial Oxidative Metabolism and Lipogenesis Synergistically Adapt to Mediate Healthy Embryonic-to-Neonatal Transition in Chicken. | 2019 | Details |
| A09095 | 31877961 | Nutrients | Switching to a Healthy Diet Prevents the Detrimental Effects of Western Diet in a Colitis-Associated Colorectal Cancer Model. | 2019 | Details |
| A09097 | 31877680 | Int J Mol Sci | Mechanistic Insight of Na/K-ATPase Signaling and HO-1 into Models of Obesity and Nonalcoholic Steatohepatitis. | 2019 | Details |
| A09101 | 31876010 | Microcirculation | Pyridoxamine improves metabolic and microcirculatory complications associated with nonalcoholic fatty liver disease. | 2020 | Details |
| A09105 | 31872499 | Liver Int | Tolerogenic properties of liver macrophages in non-alcoholic steatohepatitis. | 2020 | Details |
| A09109 | 31870746 | Ann Hepatol | Peroxisomal footprint in the pathogenesis of nonalcoholic steatohepatitis. | 2019 | Details |
| A09116 | 31868169 | Med Sci Monit | Evaluation of Plateletcrit and Platelet Distribution Width in Patients with Non-Alcoholic Fatty Liver Disease: A Retrospective Chart Review Study. | 2019 | Details |
| A09119 | 31867441 | Hepatoma Res | Molecular links between non-alcoholic fatty liver disease and hepatocellular carcinoma. | 2019 | Details |
| A09122 | 31867007 | Front Immunol | Macrophages in Zebrafish Models of Liver Diseases. | 2019 | Details |
| A09136 | 31861818 | Cells | Metabolic Hallmarks of Hepatic Stellate Cells in Liver Fibrosis. | 2019 | Details |
| A09139 | 31861497 | Nutrients | Protective Effect of α-Linolenic Acid on Non-Alcoholic Hepatic Steatosis and Interleukin-6 and -10 in Wistar Rats. | 2019 | Details |
| A09146 | 31858523 | Histol Histopathol | Hepatocellular carcinoma in non-alcoholic fatty liver disease (NAFLD) - pathological evidence for a predominance of steatohepatitic inflammatory non-proliferative subtype. | 2019 | Details |
| A09151 | 31857195 | J Hepatol | ARRB1 inhibits non-alcoholic steatohepatitis progression by promoting GDF15 maturation. | 2019 | Details |
| A09152 | 31857090 | Chem Biol Interact | Sodium acetate protects against nicotine-induced excess hepatic lipid in male rats by suppressing xanthine oxidase activity. | 2019 | Details |
| A09156 | 31853615 | Naunyn Schmiedebergs Arch Pharmacol | Adelmidrol protects against non-alcoholic steatohepatitis in mice. | 2019 | Details |
| A09187 | 31843499 | Am J Pathol | Inflammation and Ectopic Fat Deposition in the Aging Murine Liver Is Influenced by CCR2. | 2019 | Details |
| A09191 | 31841118 | Aging (Albany NY) | Effects of XIAP on high fat diet-induced hepatic steatosis: a mechanism involving NLRP3 inflammasome and oxidative stress. | 2019 | Details |
| A09206 | 31836013 | BMC Complement Altern Med | Helminthostachys zeylanica alleviates hepatic steatosis and insulin resistance in diet-induced obese mice. | 2019 | Details |
| A09210 | 31835339 | Metabolites | Acupuncture on ST36, CV4 and KI1 Suppresses the Progression of Methionine- and Choline-Deficient Diet-Induced Nonalcoholic Fatty Liver Disease in Mice. | 2019 | Details |
| A09213 | 31834465 | Naunyn Schmiedebergs Arch Pharmacol | NLRP3 inhibitor glibenclamide attenuates high-fat diet and streptozotocin-induced non-alcoholic fatty liver disease in rat: studies on oxidative stress, inflammation, DNA damage and insulin signalling pathway. | 2019 | Details |
| A09227 | 31828683 | Eur J Clin Microbiol Infect Dis | Non-alcoholic fatty liver diseases: from role of gut microbiota to microbial-based therapies. | 2019 | Details |
| A09239 | 31822739 | Sci Rep | Pharmacological myeloperoxidase (MPO) inhibition in an obese/hypertensive mouse model attenuates obesity and liver damage, but not cardiac remodeling. | 2019 | Details |
| A09241 | 31821689 | Liver Int | Longitudinal studies can identify distinct inflammatory cytokines associated with the inhibition or progression of liver cancer. | 2019 | Details |
| A09242 | 31821039 | Am J Physiol Endocrinol Metab | Amitriptyline inhibits nonalcoholic steatohepatitis and atherosclerosis induced by high-fat diet and LPS through modulation of sphingolipid metabolism. | 2019 | Details |
| A09245 | 31819934 | Food Funct | Acerola polysaccharides ameliorate high-fat diet-induced non-alcoholic fatty liver disease through reduction of lipogenesis and improvement of mitochondrial functions in mice. | 2020 | Details |
| A09247 | 31819375 | Drug Des Devel Ther | Liraglutide Improves Non-Alcoholic Fatty Liver Disease In Diabetic Mice By Modulating Inflammatory Signaling Pathways. | 2019 | Details |
| A09253 | 31817227 | Nutrients | Fermented Korean Red Ginseng Extract Enriched in Rd and Rg3 Protects against Non-Alcoholic Fatty Liver Disease through Regulation of mTORC1. | 2019 | Details |
| A09254 | 31816816 | Int J Mol Sci | MicroRNA-451 and Genistein Ameliorate Nonalcoholic Steatohepatitis in Mice. | 2019 | Details |
| A09257 | 31815784 | Curr Opin Endocrinol Diabetes Obes | Gastrointestinal peptides and nonalcoholic fatty liver disease. | 2020 | Details |
| A09271 | 31809956 | Nutrition | Intermediary effect of inflammation on the association between dietary patterns and non-alcoholic fatty liver disease. | 2019 | Details |
| A09279 | 31808236 | Hepatol Res | Serum soluble sialic acid-binding immunoglobulin-like lectin-7 concentration as an indicator of liver macrophage activation and advanced fibrosis in patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A09283 | 31806408 | Arab J Gastroenterol | Treatments of nonalcoholic fatty liver disease in adults who have no other illness: A Review article. | 2019 | Details |
| A09290 | 31804025 | Environ Toxicol | Burdock (Arctium lappa L.) root attenuates preneoplastic lesion development in a diet and thioacetamide-induced model of steatohepatitis-associated hepatocarcinogenesis. | 2019 | Details |
| A09311 | 31795627 | Clin Mol Hepatol | Limited expression of TLR9 on T cells and its functional consequences in patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A09313 | 31795130 | Nutrients | Lotus Seedpod Extracts Reduced Lipid Accumulation and Lipotoxicity in Hepatocytes. | 2019 | Details |
| A09317 | 31793207 | J Cell Mol Med | PNPLA3 I148M mediates the regulatory effect of NF-kB on inflammation in PA-treated HepG2 cells. | 2019 | Details |
| A09324 | 31790829 | Free Radic Biol Med | Lycopene prevents the progression of lipotoxicity-induced nonalcoholic steatohepatitis by decreasing oxidative stress in mice. | 2019 | Details |
| A09332 | 31788011 | Nutr Metab (Lond) | Curcumin prevents high-fat diet-induced hepatic steatosis in ApoE-/- mice by improving intestinal barrier function and reducing endotoxin and liver TLR4/NF-κB inflammation. | 2019 | Details |
| A09342 | 31784293 | Arch Pediatr | Feeding problems and gastrointestinal diseases in Down syndrome. | 2019 | Details |
| A09346 | 31783479 | Int J Mol Sci | Cerium Oxide Nanoparticles Protect against Oxidant Injury and Interfere with Oxidative Mediated Kinase Signaling in Human-Derived Hepatocytes. | 2019 | Details |
| A09350 | 31782176 | Hepatology | Lipotoxic Hepatocyte-Derived Exosomal MicroRNA 192-5p Activates Macrophages Through Rictor/Akt/Forkhead Box Transcription Factor O1 Signaling in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A09356 | 31780766 | Sci Rep | Sodium fluorocitrate having inhibitory effect on fatty acid uptake ameliorates high fat diet-induced non-alcoholic fatty liver disease in C57BL/6J mice. | 2019 | Details |
| A09363 | 31777643 | Int J Physiol Pathophysiol Pharmacol | Role of mitochondrial depolarization and disrupted mitochondrial homeostasis in non-alcoholic steatohepatitis and fibrosis in mice. | 2019 | Details |
| A09367 | 31776016 | Environ Res | Adolescent exposure to environmental level of PCBs (Aroclor 1254) induces non-alcoholic fatty liver disease in male mice. | 2019 | Details |
| A09373 | 31771682 | Br J Nutr | Crude extract of Camellia oleifera pomace ameliorates the progression of non-alcoholic fatty liver disease via decreasing fat accumulation, insulin resistance and inflammation. | 2019 | Details |
| A09383 | 31767938 | Sci Rep | Dietary wheat amylase trypsin inhibitors promote features of murine non-alcoholic fatty liver disease. | 2019 | Details |
| A09386 | 31766373 | J Clin Med | Pathophysiological Implication of Fetuin-A Glycoprotein in the Development of Metabolic Disorders: A Concise Review. | 2019 | Details |
| A09394 | 31761566 | Cell Metab | Neutralization of Oxidized Phospholipids Ameliorates Non-alcoholic Steatohepatitis. | 2019 | Details |
| A09405 | 31758951 | Metabolism | Curcumin analog CUR5-8 ameliorates nonalcoholic fatty liver disease in mice with high-fat diet-induced obesity. | 2019 | Details |
| A09407 | 31758699 | Br J Pharmacol | Naringenin attenuates non-alcoholic fatty liver disease by down-regulating the NLRP3/NF-κB pathway in mice. | 2020 | Details |
| A09408 | 31758647 | Liver Int | Hepatic NK cells attenuate fibrosis progression of non-alcoholic steatohepatitis in dependent of CXCL10-mediated recruitment. | 2019 | Details |
| A09413 | 31757759 | Mol Ther | HLSC-Derived Extracellular Vesicles Attenuate Liver Fibrosis and Inflammation in a Murine Model of Non-alcoholic Steatohepatitis. | 2019 | Details |
| A09415 | 31757735 | Presse Med | [Pharmacological treatment of NASH]. | 2019 | Details |
| A09432 | 31752378 | Nutrients | Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter? | 2019 | Details |
| A09435 | 31751137 | J Med Chem | Discovery of the First Low Nanomolar Liver Receptor Homolog-1 (LRH-1) Agonist. | 2019 | Details |